Both formulations are brand-name medications without generic alternatives currently available in the United States, resulting in substantial out-of-pocket costs for patients without adequate insurance coverage
The FDA label for Wegovy includes warnings about potential intestinal obstruction, which is particularly relevant in the postoperative setting
The SURMOUNT-1 trial showed mean weight reductions of approximately 15.0% (5 mg dose), 19.5% (10 mg dose), and 20.9% (15 mg dose) at 72 weeks
GSH is the most abundant endogenous antioxidant in the brain and plays an important role in counteracting oxidative stress (Lu, 2013
In an effort to better understand the access challenges across the US, Hims & Hers introduced the GLP-1 Supply Tracker to help more individuals share their experiences and use their voice to ensure the FDA has the information it needs to better support accessible care
Through a platform like RxSpan MD, a prescription requires review by an independent licensed healthcare provider, and approval is not guaranteed